about
Pleuromutilins: use in food-producing animals in the European Union, development of resistance and impact on human and animal healthAttribution of the French human Salmonellosis cases to the main food-sources according to the type of surveillance data.Simultaneous determination of six quinolones in pig muscle by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry.Combined antimicrobial resistance in Enterococcus faecium isolated from chickens.Antibiotic resistance in bacteria of animal origin: methods in use to monitor resistance in EU countries.Pharmaco-epidemiology and -economics should be developed more extensively in veterinary medicine.Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans.Tests for determining in-use concentrations of antibiotics and disinfectants are based on entirely different concepts: "resistance" has different meanings.Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health.Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects.What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe?Macrolides and lincosamides in cattle and pigs: use and development of antimicrobial resistance.Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.Low in vitro permeability of the cyanotoxin microcystin-LR across a Caco-2 monolayer: with identification of the limiting factors using modelling.In vitro combined cytotoxic effects of pesticide cocktails simultaneously found in the French diet.Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014.Estimation of transmission parameters of a fluoroquinolone-resistant Escherichia coli strain between pigs in experimental conditions.Pharmacokinetic/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: comparison of bactericidal activity at the gut versus the systemic level in a pig model.Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.Bioavailability, distribution and depletion of monensin in chickens.Stochastic modeling in toxicokinetics. Application to the in vivo micronucleus assay.Effects of griseofulvin in medium-term liver carcinogenesis assay and peripheral blood micronucleus test in rat.A survey of group-level antibiotic prescriptions in pig production in France.Impact of antimicrobial drug usage measures on the identification of heavy users, patterns of usage of the different antimicrobial classes and time-trends evolution.Application of pharmacokinetic/pharmacodynamic and stochastic modelling to 6-mercaptopurine micronucleus induction in mouse bone marrow erythrocytes.Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs.Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use.Phenotypes and genotypes of campylobacter strains isolated after cleaning and disinfection in poultry slaughterhouses.The Bayesian microbial subtyping attribution model: robustness to prior information and a proposition.Marine toxin okadaic acid induces aneuploidy in CHO-K1 cells in presence of rat liver postmitochondrial fraction, revealed by cytokinesis-block micronucleus assay coupled to FISH.Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys.Validation of a multi-residue liquid chromatography-tandem mass spectrometry confirmatory method for 10 anticoccidials in eggs according to Commission Decision 2002/657/EC.Cytochrome P450-dependent metabolism of monensin in hepatic microsomes from chickens and turkeys.Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.European Proficiency testing of national reference laboratories for the confirmation of sulfonamide residues in muscle and milk.Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.Trends in antimicrobial resistance phenotypes in non-typhoid Salmonellae from human and poultry origins in France.Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.The Monitoring of Triphenylmethane Dyes in Aquaculture Products Through the European Union Network of Official Control Laboratories.
P50
Q27015971-50354979-16E2-4BFA-8545-0C4A78903E53Q30596393-BC963768-C87D-491C-88D7-7D5110B10F6FQ33420905-3E502030-F000-488D-9C90-F10724E34882Q33769783-65D69C06-EE80-4363-85F9-CFEFAD88C160Q33993572-E798DB64-BAEB-4D8C-B8C9-E69A47AD1A4FQ35027012-A0E8F614-585E-494D-A4B6-0617E8A4F31CQ36795941-771347A8-8A16-46EF-AADC-830F138FAE1EQ37620867-B9F2479C-AEEE-47D3-8D73-28C09E4A9B08Q37689225-9BBCB57A-2DAB-4D45-B224-B31124F0E288Q37826872-DBC15B9A-B6A1-4905-8997-3BA7C016E909Q38146320-26252C97-8AD4-4053-ACF9-1D91F9F24F1AQ38200735-AA5242B8-7E5C-4369-9876-DE956198A864Q38555398-43DEDC74-FD65-43DD-AFD9-B9E06BB3E6E7Q38967272-16605067-9E34-4198-8226-649E36FC6362Q39242338-5CC7CAB9-6011-4FC4-8A83-E840B32FE978Q40783604-CE54A1A1-46C3-45C8-B670-0133EF3FA4F1Q42022140-9E094DEB-9CC6-4BC5-AE2F-F975C9821348Q42248243-F6F41B83-23BF-4FF1-A5BA-8C1DD5154D72Q42583041-0726C2E4-9B9E-41F2-AA85-DF27C80FBD25Q42612081-85A39BE4-F6DD-4491-B5A7-43ECF125AC39Q43276470-7D08A7FC-194E-42AB-B263-22D555E9E369Q43515192-878D6F4C-EA05-4232-A9F9-D4B5693B8033Q43825190-574EACD3-D0B0-489B-9A25-FC97E18CDEBCQ44154693-6FAB71C6-C22F-44C3-AAB9-6E19CCA5667FQ44182110-9DDDE607-32AE-4236-9D16-23D7261DAC2AQ44272402-197F414D-2536-4EC0-877E-4419CD944EC9Q44311560-BEE094B4-5A0D-4FA7-A5F9-C7B17EC07EC5Q44617842-B074935D-A7A4-4210-BEAB-81F5CC758834Q44679894-0738CBFF-3942-4239-8153-B2E3A1B0EB46Q44704291-D9F3FEB2-A4DA-4466-BDEF-9E3D4C2EC759Q44810349-2A550E29-0827-449F-8149-91BF76FEAA89Q45259765-8893D9B6-D1E9-41C6-856F-546E8021BACCQ46011742-0CE6B059-B498-46A1-B5AD-521B5E8B2E7AQ46253994-64EA3E3F-4677-4053-B620-980B119B82A2Q46553647-8E80046C-530E-46D8-AB26-653A37358F91Q46602407-23DD599A-3334-48EB-9612-FB3622286FF5Q46673206-D8037849-B76D-4514-B713-40933D467EB1Q46892375-920F4065-DF33-4E2C-948E-0E9A387F9C62Q50082656-80A39836-CD71-48C5-B1E5-ECE205811070Q50271827-3CDF854C-F07F-4F8D-A922-A1C723CC04D0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pascal Sanders
@ast
Pascal Sanders
@en
Pascal Sanders
@es
Pascal Sanders
@nl
Pascal Sanders
@sl
type
label
Pascal Sanders
@ast
Pascal Sanders
@en
Pascal Sanders
@es
Pascal Sanders
@nl
Pascal Sanders
@sl
prefLabel
Pascal Sanders
@ast
Pascal Sanders
@en
Pascal Sanders
@es
Pascal Sanders
@nl
Pascal Sanders
@sl
P106
P1153
57125547500
7201703167
P21
P31
P496
0000-0003-4019-480X
P569
2000-01-01T00:00:00Z